Casandra
Casandra Test Code AR25067Version 1 (DRAFT)
Performing Lab
COVID‑19 IgG (Spike), Semi‑Quantitative by CIA (Inactive as of 09/03/24)
Also known as: COV19G SQ
Clinical Use
Order TestUse
Use for the detection of IgG antibodies against the spike (S1) protein of SARS‑CoV‑2 that develop in response to natural infection or COVID‑19 vaccination. Not intended for assessment of protective immunity or vaccine response interpretation.
Special Instructions
Not provided.
Limitations
This test is inactive as of September 3, 2024. There is no recommendation for assessing vaccine response; results cannot determine immunity level or differentiate infection vs vaccination.
Test Details
Methodology
Immunoassay (CLIA)
Biomarkers
IgG (Spike)
ProteinSemi‑Quantitative CLIA • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided